Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo-Reference-Cited by-同舟云学术

Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo

Published:2014-01-12 Issue:7 Volume:5 Page:1761-1769
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Heap John T.¹²,Theys Jan³,Ehsaan Muhammad¹,Kubiak Aleksandra M¹,Dubois Ludwig³,Paesmans Kim³,Van Mellaert Lieve⁴,Knox Richard⁵,Kuehne Sarah A.¹,Lambin Phillipe³,Minton Nigel P.¹

Affiliation:

1. Clostridia Research Group, Centre for Biomolecular Sciences, School of Life Sciences, The University of Nottingham, University Park, Nottingham, UK

2. Present address: Centre for Synthetic Biology and Innovation, Department of Life Sciences, Imperial College London, London, UK

3. Maastro Lab, Research Institute GROW, University of Maastricht, MD Maastricht, The Netherlands

4. Molecular Bacteriology, Rega Institute for Medical Research, University Leuven, Minderbroedersstraat,Belgium

5. Morvus Technology Limited, Ty Myddfai, Llanarthne, Carmarthen, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Hazard Associated with the Presence of Clostridium Bacteria in Food Products;Foods;2024-08-18

2. Exploiting bacteria for cancer immunotherapy;Nature Reviews Clinical Oncology;2024-06-05

3. Programmable cancer treatments: Engineering biology approaches for living cures;Engineering Biology;2024-05-31

4. Modulation of gut‐microbiota through probiotics and dietary interventions to improve host health;Journal of the Science of Food and Agriculture;2024-02-19

5. Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?;Critical Reviews in Microbiology;2024-02-12